- Market Capitalization, $K 21,466,558
- Shares Outstanding, K 147,984
- Annual Sales, $ 862,210 K
- Annual Income, $ 229,830 K
- 60-Month Beta 1.28
- Price/Sales 24.53
- Price/Cash Flow 93.35
- Price/Book 14.84
|Period||Period Low||Period High||Performance|
| || |
-8.30 (-5.55%)since 09/20/19
| || |
-27.45 (-16.26%)since 07/22/19
| || |
+49.71 (+54.26%)since 10/22/18
Veeva Systems (VEEV) closed the most recent trading day at $148.89, moving -0.66% from the previous trading session.
Veeva Systems-A (NYSE:VEEV) traded in a range yesterday that spanned from a low of $154.66 to a high of $157.24. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of...
SmarTrend identified a Downtrend for Veeva Systems-A (NYSE:VEEV) on September 26th, 2019 at $155.79. In approximately 2 weeks, Veeva Systems-A has returned 3.53% as of today's recent price of $150.29....
In the latest trading session, Veeva Systems (VEEV) closed at $150.25, marking a +0.62% move from the previous day.
We looked at the Health Care Technology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. ...
Veeva Systems (VEEV) closed at $148.97 in the latest trading session, marking a -1.38% move from the prior day.
Veeva Systems-A (NYSE:VEEV) traded in a range yesterday that spanned from a low of $141.88 to a high of $151.23. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $147.51...
--Veeva aims to help industry accelerate clinical research and streamline study start-up and execution across sites and sponsors
Veeva Systems (NYSE:VEEV) today announced that Repsco, the largest contract sales organization in France, has standardized on Veeva CRM for all their teams. A longtime partner to the life sciences industry,...
The latest acquisition fortifies Veeva Systems' (VEEV) foothold in the HCIT space further.